WXXWY (WXXWY) Stock Price & Analysis
WXXWY (WXXWY) fell 0.71% to USD 9.84 as of July 25, 2026 at 03:03 UTC, according to Nexqual real-time market data.
WXXWY last closed at USD 9.91; the session ranged USD 9.67–9.85 on volume of 4,727 shares. Market capitalization is $20.20B, with a 52-week range of USD 7.27–11.21 (PNK). Source: Nexqual, July 25, 2026 at 03:03 UTC.
Key Statistics (as of July 25, 2026 at 03:03 UTC)
| Price | USD 9.84 |
|---|---|
| Change | ▼ 0.71% (down) |
| Previous Close | USD 9.91 |
| Open | USD 9.67 |
| Day Range | USD 9.67 – 9.85 |
| 52-Week Range | USD 7.27 – 11.21 |
| Volume | 4,727 shares |
| Market Cap | $20.20B |
| Exchange | PNK |
Technical Analysis (WXXWY)
Nexqual's technical model rates WXXWY "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of July 25, 2026 at 03:03 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.55 (neutral) |
| vs SMA50 | Above (USD 8.67) |
| MACD | 0.38 (positive) |
Analyst Ratings (WXXWY)
Wall Street analysts rate WXXWY "None", per Nexqual as of July 25, 2026 at 03:03 UTC.
| Consensus Rating | None |
|---|
Earnings (WXXWY)
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Financials & Fundamentals (WXXWY)
| Total Revenue | $21.79B |
|---|---|
| Revenue Growth (YoY) | +17.20% |
| Gross Margin | +45.98% |
| Operating Margin | +33.14% |
| Profit Margin | +22.53% |
| ROE | +11.64% |
| Debt / Equity | 5.85 |
| Current Ratio | 3.39 |
| Total Cash | $15.73B |
| Total Debt | $3.10B |
| Free Cash Flow | $4.28B |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Financial Health Score (WXXWY)
Nexqual rates WXXWY's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 03:03 UTC.
| Growth | Strong — Revenue +17% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 46%, operating 33% |
| Balance Sheet | Strong — $15.7B cash vs $3.10B debt, net cash position |
| Cash Flow | Strong — FCF $4.28B, 20% margin |
| Efficiency | Mixed — ROE 12%, ROA 6.9% |
Ownership (WXXWY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 2.05B |
| Float | 1.87B |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Leadership (WXXWY)
WXXWY is led by Zhisheng Chen (age 52), CEO & Executive Director, per Nexqual as of July 25, 2026 at 03:03 UTC.
| CEO & Executive Director | Zhisheng Chen (age 52) |
|---|---|
| Founder & Chairman | Ge Li (age 58) |
| CFO & Executive VP | Ming Tu (age 56) |
| COO & Senior VP | Lihua Yu |
| Chief Scientific Officer & President of Global Biologics Research | Jijie Gu (age 59) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WXIBF | Wuxi Biologics (Cayman) Inc | USD 4.6 | ▲ 0% |
| MKKGY | Merck KGaA | USD 31.88 | ▲ 2.02% |
| MPNGY | MEITUAN | USD 22.08 | ▲ 3.23% |
| UCBJY | UCB S.A. | USD 139.01 | ▼ 0.04% |
| SAUHY | Straumann Holding AG | USD 11.64 | ▼ 1.61% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:03 UTC. This page is informational and not investment advice.